Gurus Invest in Undervalued Biotech Stocks

Gurus Invest in Undervalued Biotech Stocks


Among companies trading on the New York Stock Exchange and the Nasdaq, health care companies trade significantly below their median price-sales valuation . At least five companies made the " Undervalued Biotech " screener, including Biogen Inc. , Gilead Sciences Inc. , JAZZ Pharmaceuticals PLC , Novo Nordisk A/S and United Therapeutics Corp. .



from Biotech News